Mariangela Ciccarese
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Multidisciplinary discussion on phenotypical characterization of metastatic breast cancer and patient pathway optimization from an expert panel across South Italian regions.
Journal: Scientific reports
Published: November 18, 2024
Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health.
Journal: Oncotarget
Published: February 22, 2024
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: January 15, 2024
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial.
Journal: Breast (Edinburgh, Scotland)
Published: January 06, 2024
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.
Journal: Scientific reports
Published: April 06, 2023
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland.
Journal: Journal of cancer survivorship : research and practice
Published: February 16, 2022
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
Journal: Breast cancer research : BCR
Published: February 02, 2022
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Journal: Oncology
Published: October 04, 2021
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.
Journal: Breast cancer research and treatment
Published: August 13, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2020
Biosensing Cytokine IL-6: A Comparative Analysis of Natural and Synthetic Receptors.
Journal: Biosensors
Published: July 15, 2020
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
Journal: The breast journal
Published: March 30, 2020
Last Updated: 09/26/2026